Oligonucleotide delivery to tumours using macromolecular carriers

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Drug Delivery Systems

Background:

• Microparticles are established carriers for chemo- and radio-therapeutic agents in cancer treatment.
• Cationic liposomes have a decade-long history in delivering nucleic acids into mammalian cells.

Purpose of the Study:

• To review the potential and obstacles of using cationic liposomes for delivering therapeutic oligonucleotides (ONs) to tumors.
• To propose microparticle-based strategies for ON delivery to solid tumors.
• To discuss prospects and methods for enhancing ON delivery using these carriers.

Main Methods:

• Literature review and synthesis of existing research on microparticle and cationic liposome drug delivery.
• Analysis of challenges associated with oligonucleotide delivery to tumor sites.
• Exploration of potential applications and improvements for nanoparticle-based therapeutic delivery.

Main Results:

• Cationic liposomes show potential for therapeutic ON delivery but face significant obstacles.
• Microparticles offer a viable alternative for delivering ONs to solid tumors.
• Various strategies can be employed to improve the efficacy of ON delivery systems.

Conclusions:

• Both microparticles and cationic liposomes hold promise for oligonucleotide-based cancer therapy.
• Overcoming delivery barriers is crucial for successful clinical translation.
• Further research into carrier design and optimization is needed to enhance therapeutic outcomes.